The University of Colorado Diabetes Research Center (UC DRC), established in 2020, is one of 16 Diabetes Research Centers supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) across the United States.
It is comprised of basic, translational, and clinical researchers whose diverse research programs focus on Type 1 and Type 2 diabetes, diabetes complications, and autoimmunity. The DRC facilitates their research endeavors by providing efficient and innovative shared resources, developing enrichment programs to facilitate interactions and collaborations between center members, and implementing a strong pilot and feasibility program to bring new investigators into the diabetes field. These efforts result in an improved understanding of disease etiologies and progression and promote the development of diabetes treatments and cures.
Led by Director Dr. Lori Sussel, PhD, and Co-director Dr. Jane Reusch, MD, the UC DRC is dedicated to advancing diabetes research and improving outcomes for individuals living with diabetes. Located on the Anschutz Medical Campus in Aurora, Colorado, the UC DRC serves as a hub for groundbreaking diabetes research, benefiting from the collaborative environment of the University of Colorado's clinical and research departments.
NIDDK-supported Diabetes Research Centers (DRCs) are part of an integrated program of diabetes and related endocrinology and metabolism research. They support extramural research institutions that have established an existing base of high-quality, diabetes-related research.
DRCs are intended to improve the quality and multidisciplinary nature of research on diabetes by providing shared access to specialized technical resources and expertise. They also facilitate progress in research with the goal of developing new methods to treat, prevent and ultimately cure diabetes mellitus and its complications.